UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make ...

Newly back in the CEO chair at UnitedHealth Group, Stephen Hemsley on Monday vowed to address a series of lightning-rod ...

UnitedHealth Group shares appear undervalued after 50% decline, and concerns about a potential DOJ investigation seem ...

UnitedHealth Group's new CEO Steve Hemsley on Monday told shareholders he was determined to earn back their trust after its ...

UnitedHealth Group has had a difficult year marked by a dramatic stock drop, leadership shake-up and mounting regulatory scrutiny. Experts point to its aggressive Medicare Advantage strategy and a ...